Alcon Inc. (ALC) Stock
ALC Key Statistics
About Alcon Inc.
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
CEO: David J. Endicott. Company website
ALC — Frequently Asked Questions
What is the ALC stock price today?
Alcon Inc. (ALC) trades at $65.04, down 0.21% on the day, as of Sep 20, 2026 14:59 UTC.
What is Alcon Inc.'s market cap?
Alcon Inc. has a market capitalisation of $31.72B, calculated from the live ALC share price and shares outstanding.
What is the P/E ratio of ALC?
ALC trades at a trailing P/E of 50.03, from earnings per share of $1.30 over the last twelve months.
How much revenue does Alcon Inc. make?
Alcon Inc. generated revenue of $10.81B over the trailing twelve months, which puts the stock at 2.93 times sales.
What is the 52-week range for ALC?
ALC has traded between $61.84 and $87.64 over the past 52 weeks, and the last price is 25.8% below that high.
Is Alcon Inc. profitable?
Yes. Alcon Inc. keeps 5.92% of revenue as net income over the trailing twelve months.
What is the analyst price target for ALC?
Wall Street analysts rate ALC Buy, with an average price target of $73.43, 12.9% above the current price.
What sector is Alcon Inc. in?
Alcon Inc. is classified under the Healthcare sector and the Medical - Specialties industry, and is domiciled in CH.
Who is the CEO of Alcon Inc.?
David J. Endicott is the chief executive of Alcon Inc., which employs 25,000 people.
Where can I track ALC in real time?
QFI Terminal shows ALC with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See ALC live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open ALC in Terminal See plans